Life sciences IP & pharmaceutical research often requires professionals to work across disconnected biological, chemical, and drug development data. Moving between these information sources can make it difficult to trace an innovation from its underlying sequence or chemical structure to related drugs, clinical trials and competitive pipelines.

You'll learn how to:

• • Investigate biologic drugs from sequence through clinical development by linking Synapse drug and pipeline intelligence with related sequence and biologic patents in Bio.
    
  • Explore small-molecule innovation from structure to pipeline by moving between Synapse and Chemical to uncover chemical structures, similar compounds, associated patents and drug activity.
    
  • Build an integrated view across biological, chemical and drug intelligence to identify competitors, assess emerging opportunities and support strategic decisions.
    

• Stay for a live Q&A, where our experts answer your specific questions and share pro tips.